Bluefin Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-36,133
Closed -$2.85M 280
2022
Q4
$2.85M Sell
36,133
-23,242
-39% -$1.74M 0.42% 43
2022
Q3
$4.17M Buy
+59,375
New +$4.66M 0.38% 51
2021
Q1
Sell
-4,392
Closed -$376K 810
2020
Q4
$376K Buy
+4,392
New +$363K 0.02% 334
2020
Q1
Sell
-33,008
Closed -$2.27M 458
2019
Q4
$2.27M Buy
+33,008
New +$2.25M 0.15% 142
2019
Q3
Sell
-849,810
Closed -$61.7M 521
2019
Q2
$60.9M Buy
+849,810
New +$60.3M 8.62% 3
2017
Q4
Sell
-16,727
Closed -$1.22M 497
2017
Q3
$1.22M Sell
16,727
-31,145
-65% -$2.24M 0.14% 131
2017
Q2
$3.55M Sell
47,872
-45,915
-49% -$3.41M 0.38% 54
2017
Q1
$6.86M Buy
+93,787
New +$6.56M 0.9% 21
2014
Q3
Sell
-13,098
Closed -$900K 949
2014
Q2
$900K Buy
+13,098
New +$878K 0.04% 329
2014
Q1
Sell
-26,200
Closed -$1.71M 470
2013
Q4
$1.71M Buy
+26,200
New +$1.68M 0.13% 152

Other funds holding CL

Bluefin Capital Management's CL Position: Q1 2023 in Review

Bluefin Capital Management sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 36,133 shares — an estimated $2.85M sold.

Bluefin Capital Management first reported a position in CL in Q4 2013 and held it in 10 quarters. The position peaked at $60.9M in Q2 2019. 1,657 funds tracked by Wall St. Rank hold CL as of Q1 2023.

  • Bluefin Capital Management reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
  • Bluefin Capital Management sold 36,133 Colgate-Palmolive shares in Q1 2023, an estimated $2.85M.
  • Bluefin Capital Management first reported a position in Colgate-Palmolive in Q4 2013 and held it in 10 quarters.
  • Bluefin Capital Management's Colgate-Palmolive position peaked at $60.9M in Q2 2019.
  • 1,657 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Bluefin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.